医学ppt--用药错误及其防范

(2) to promote framing of evidence-based policies, including global standards that will improve patient care, with particular emphasis on such aspects as product safety, safe clinical practice … and safe use of medicinal products and medical devices, and creation of a culture of safety within health care organizations.
REQUESTS Director-General: …
(3) to provide support for implementation of drug monitoring systems in order better to identify developing resistance, adverse reactions and misuse of drugs within health systems, thus promoting rational use of drugs;
医学ppt--用药错误及其防范
提要
一、引言 二、ME的定义 三、危害 四、分类 五、原因 六、因素 七、防范对策 八、政府干预的建议 九、结语
2020/12/6
Da-You Wang, Huashan Hospital
2
World Health Assembly resolution 54.11,
significant avoidable cause of human suffering, and high toll in financial loss and opportunity cost to health services;
Noting that significant enhancement of health systems’ performance can be achieved … by preventing adverse events in particular, and improving patient safety and health care quality in general;
2020/12/6
Da-You Wang, Huashan Hospital
6
引言
• 事实是近年来药源性损害事件在我国 不断上升，有的造成医疗纠纷，有的 酿成医疗事故，不但给病人造成损害， 对医疗机构亦直接造成经济损失，甚 而严重影响了医疗机构的声誉。
2020/12/6
Da-You Wang, Huashan Hospital
3ห้องสมุดไป่ตู้
World Health Assembly resolution,
May 2002: Quality of Care: Patient Safety
… Concerned that the incidence of adverse events is a challenge to quality of care, a
• 医务人员不仅在主观上、动机上， 还要在客观上、效果上努力维护 病人健康，对病人不产生伤害。
2020/12/6
Da-You Wang, Huashan Hospital
5
一、引 言
合理用药的第一要素是安全， WHO、国家卫生部领导又反复 强调医疗安全的重要性，那么 目前医疗机构的用药安全情况 到底怎么了？
REQUESTS Director-General: …
(1) to develop global norms, standards and guidelines for the definition, measurement and reporting of adverse events..., and to provide support to countries in developing reporting systems, taking preventive action … ;
21 May 2001: WHO Medicines Strategy
… bearing in mind the previous report on the subject, that highlight challenges
related to the international trade agreements, access to essential drugs, drug quality and rational use of medicines, together with the urgent need to improve access to treating priority health problems such as malaria, childhood illnesses, HIV/AIDS and tuberculosis, among others;
(6) to provide support to Member States to set up efficient national regulatory mechanisms for quality assurance that will help ensure compliance with good manufacturing practices, bioavailability and bioequivalence
2020/12/6
Da-You Wang, Huashan Hospital
4
马晓伟副部长部长在2005年4月18日卫 生部医院管理年工作会议上的报告
• 努力提高卫生行政部门管理、统筹、 协调医院工作的能力，提高对医院 的指导、检查、评价、管理和监督 能力。
• 严防医疗事故，减少医患纠纷， 保障医疗安全，提高医疗服务的 安全性和有效性。